REG - NetScientific PLC - Exercise of Options

NetscientificAnnouncement

13/10/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231013:nRSM9957Pa&default-theme=true

RNS Number : 9957P  NetScientific PLC  13 October 2023

For release: 07.00, 13 October 2023

 

 

 

 

NetScientific plc

 

("NetScientific" or the "Company")

 

Exercise of Options

 

NetScientific plc (AIM: NSCI), the deeptech and life sciences VC investment
group, announces the exercise by Prof Stephen Smith (who recently retired as a
Non-Executive Director) of options over 46,155 ordinary shares in the capital
of NetScientific Plc ("Ordinary Shares") for an aggregate exercise price of
£21,000.53.

Application will be made for 46,155 new Ordinary Shares, which will rank
pari passu with existing Ordinary Shares, to be admitted to AIM ("Admission").
It is expected that Admission will become effective and dealings will commence
at 8.00 a.m. on or around 19 October 2023.

Following Admission, the total issued share capital of the Company will
consist of 23,574,303 Ordinary Shares ("Enlarged Issued Share Capital"). The
Company does not hold any shares in treasury. Therefore, the total number of
voting rights in the Company will be 23,574,303 Ordinary Shares. This number
may be used by shareholders as the denominator for the calculations by which
they will determine if they are required to notify their interest, or a change
to their interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.

 

#  #  #

 

For more information, please contact:

 

 NetScientific
 Ilian Iliev, CEO                                  Via Belvedere Communications

 WH Ireland (NOMAD, Financial Adviser and Broker)
 Chris Fielding / Darshan Patel / Isaac Hooper     +44 (0)20 7220 1666

 Belvedere Communications

 John West / Llew Angus                            +44 (0)20 3008 6867

 

About NetScientific

NetScientific plc (AIM: NSCI) is a deeptech and life sciences VC investment
group with an international portfolio of innovative companies.

NetScientific identifies, invests in, and builds high growth companies in the
UK and internationally. The company adds value through the proactive
management of its portfolio, progressing to key value inflection points, and
delivering investment returns through partial or full liquidity events.

NetScientific differentiates itself by employing a capital-efficient
investment approach, making judicial use of its balance sheet and syndicating
investments through its wholly owned VC subsidiary, EMV Capital. The group
secures a mixture of direct equity stakes and carried interest stakes in its
portfolio of companies, creating a lean structure that can support a large
portfolio.

NetScientific is headquartered in London, United Kingdom, and is admitted to
trading on AIM, a market operated by the London Stock Exchange.

www.netscientific.net (http://www.netscientific.net/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FURBIBDGUXBDGXD